Articles related to Oncology, Medical

Treatment options for platinum‑resistant ovarian cancer remain limited. New phase 3 survival data suggest that adding a novel agent to standard chemotherapy may meaningfully extend survival for this hard‑to‑treat population.

Breast cancer screening remains a persistent area of variation in clinical practice. Updated guidance from the American College of Physicians aims to clarify when screening offers meaningful benefit for average‑risk patients — and when it may not.

Supplemental MRI for women with extremely dense breasts and higher-than-average risk “could be cost-effective if MRI costs and false-positive biopsy rates are reduced.” — Tosteson et al., Annals of Internal Medicine

The current real-world cohort study examines long-term survival outcomes in the 5 years after a COVID-19 hospitalization for adults with a solid malignancy. The study assessed the impact of vaccination status, vaccine platform, primary tumor site, and cancer treatment.

The new method, called MethylScan, works by analyzing cell-free DNA (cfDNA), which carries molecular signals that reflect what is happening throughout the body.

These revised evidence-based recommendations inform clinical decision-making in the management of DTC that reflect the changing science and optimize the evidence-based clinical care of patients throughout their journey with DTC.